- Highly efficient cash conversion (102% FCF/OCF ratio)
- Lower volatility than the market (beta 0.91)
- Established player in the Healthcare sector
Replimune Group Inc. stock price ended at $8.88 on Friday, after gaining 3.02%
(Updated on Jun 12, 2026)
The Replimune Group Inc. stock price gained 3.02% on the last trading day (Friday, 12th Jun 2026), rising from $8.62 to $8.88. During the last trading day the stock fluctuated 8.29% from a day low at $8.56 to a day high of $9.27. The price has been going up and down for this period, and there has been a 2.19% gain for the last 2 weeks. Volume fell on the last day by -67 thousand shares and in total, 2 million shares were bought and sold for approximately $17.44 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $10.10 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 11.64% during the next 3 months and, with a 90% probability hold a price between $2.70 and $11.27 at the end of this 3-month period.
REPL Signals & Forecast
The Replimune Group Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $9.07. On a fall, the stock will find some support from the long-term average at approximately $5.55. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, June 03, 2026, and so far it has fallen -11.02%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Replimune Group Inc. stock
Replimune Group Inc. finds support from accumulated volume at $8.87 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.710 between high and low, or 8.29%. For the last week, the stock has had daily average volatility of 9.25%.
Our recommended stop-loss: $8.43 (-5.04%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 7 days ago.)
Trading Expectations (REPL) For The Upcoming Trading Day Of Monday 15th
For the upcoming trading day on Monday, 15th we expect Replimune Group Inc. to open at $8.90, and during the day (based on 14 day Average True Range), to move between $8.43 and $9.33, which gives a possible trading interval of +/-$0.89 (+/-10.60%) up or down from last closing price. If Replimune Group Inc. takes out the full calculated possible swing range there will be an estimated 10.60% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $8.87 (0.11%) than the resistance at $9.00 (1.35%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Replimune Group Inc. will release earnings BMO on Thursday, June 18, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.730. We will update the financials statements for Replimune Group Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 10.06% in the first trading day after earnings release.
Is Replimune Group Inc. stock A Buy?
Replimune Group Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
0.196
Hold/Accumulate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 15, 2026 - $8.90 ( 0.263%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
REPL Performance
Trading levels for REPL
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 9.61 | 8.26% |
| R2 | 9.34 | 5.20% |
| R1 | 9.17 | 3.32% |
| Price | 8.88 | |
| S1 | 8.63 | -2.79% |
| S2 | 8.46 | -4.68% |
| S3 | 8.19 | -7.73% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 9.98 | 12.39% |
| R2 | 9.87 | 11.15% |
| R1 | 9.00 | 1.35% |
| Price | 8.88 | |
| S1 | 8.87 | -0.113% |
| S2 | 8.69 | -2.14% |
| S3 | 6.98 | -21.40% |
FAQ
Click here for our free guide on how to buy Replimune Group Inc. Stock.
Buy REPL